Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

The goal of the COMBISCREEN project is to develop a fully molecular cervical screening and triage approach that is applicable on self-samples, which are an easily accessible and non-invasive source of biomarkers. The project allows a one-step screening and triage modality and thereby identifies women with clinically relevant disease that are in need of treatment.

NCT Number	NCT06598176
Lead Sponsor	Universiteit Antwerpen Collaborators: University Hospital, Antwerp
Conditions	Uterine Cervical Neoplasm, Uterine Cervical Dysplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
Enrollment	100 participants
Start Date	2024-03-28
Primary Completion	2027-02-28 (estimated)
Study Completion	2037-02-28 (estimated)
Updated on ClinicalTrials.gov	2024-09-19